Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study.
Pasic I, Moya TA, Remberger M, Chen C, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J. Pasic I, et al. Among authors: remberger m. Transplant Cell Ther. 2024 Apr 20:S2666-6367(24)00367-1. doi: 10.1016/j.jtct.2024.04.014. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38648898
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study.
Carreira AS, Salas MQ, Remberger M, Basso IN, Law AD, Lam W, Pasic I, Kim D, Michelis FV, Viswabandya A, Gerbitz A, Lipton JH, Husain S, Kumar R, Mattsson J. Carreira AS, et al. Among authors: remberger m. Transplant Cell Ther. 2022 Jan;28(1):50.e1-50.e8. doi: 10.1016/j.jtct.2021.10.008. Epub 2021 Oct 14. Transplant Cell Ther. 2022. PMID: 34656808 Free article.
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Salas MQ, Pasic I, Remberger M, Novitzky-Basso I, Law AD, Lam W, Chen C, Kim DDH, Michelis FV, Gerbitz A, Viswabandya A, Lipton JH, Kumar R, Mattsson J. Salas MQ, et al. Among authors: remberger m. Transplant Cell Ther. 2022 May;28(5):265.e1-265.e9. doi: 10.1016/j.jtct.2022.02.001. Epub 2022 Feb 6. Transplant Cell Ther. 2022. PMID: 35139398 Free article.
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation.
Prem S, Remberger M, Alotaibi A, Lam W, Law AD, Kim DDH, Michelis FV, Al-Shaibani Z, Lipton JH, Mattsson J, Viswabandya A, Kumar R, Ellison C. Prem S, et al. Among authors: remberger m. Transpl Infect Dis. 2022 Aug;24(4):e13879. doi: 10.1111/tid.13879. Epub 2022 Jul 13. Transpl Infect Dis. 2022. PMID: 35706108
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation.
Santos Carreira A, Salas MQ, Remberger M, Novitzky-Basso I, Law AD, Lam W, Pasic I, Mazzulli T, Cserti-Gazdewich C, Kim DDH, Michelis FV, Viswabandya A, Gerbitz A, Lipton JH, Kumar R, Hassan M, Mattsson J. Santos Carreira A, et al. Among authors: remberger m. Transplant Cell Ther. 2023 Sep;29(9):581.e1-581.e8. doi: 10.1016/j.jtct.2023.07.007. Epub 2023 Jul 10. Transplant Cell Ther. 2023. PMID: 37437765
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
Alfaro Moya T, Mattsson J, Remberger M, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Gerbitz A, Pasic I, Novitzky-Basso I, Michelis FV. Alfaro Moya T, et al. Among authors: remberger m. Eur J Haematol. 2023 Oct;111(4):553-561. doi: 10.1111/ejh.14041. Epub 2023 Jul 18. Eur J Haematol. 2023. PMID: 37461810
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Pereira MP, Remberger M, Chen C, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J, Pasic I. Pereira MP, et al. Among authors: remberger m. Transplant Cell Ther. 2023 Nov;29(11):697.e1-697.e10. doi: 10.1016/j.jtct.2023.08.009. Epub 2023 Aug 12. Transplant Cell Ther. 2023. PMID: 37579919
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.
Pang I, Chen P, Trinh GV, Remberger M, Novitzky-Basso I, Gerbitz A, Kim DD, Kumar R, Lam W, Law AD, Lipton JH, Viswabandya A, Pasic I, Mattsson J, Michelis FV. Pang I, et al. Among authors: remberger m. Eur J Haematol. 2024 Feb;112(2):301-309. doi: 10.1111/ejh.14117. Epub 2023 Oct 13. Eur J Haematol. 2024. PMID: 37830403
302 results